{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:25:28Z","timestamp":1788924328294,"version":"build-2803163510"},"reference-count":126,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.tem.2025.06.003","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:10:29Z","timestamp":1751425829000},"page":"230-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Unraveling the sweet connection between pancreatic cancer and hyperglycemia"],"prefix":"10.1016","volume":"37","author":[{"given":"Zo\u00eb","family":"Post","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dauris","family":"Rosario Lora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1091-2989","authenticated-orcid":false,"given":"Wojciech","family":"Blogowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2025.06.003_bb0005","first-page":"1509","article-title":"Trends in pancreatic cancer mortality in the United States 1999-2020: a CDC database population-based study","volume":"35","author":"Didier","year":"2024","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.tem.2025.06.003_bb0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.seminoncol.2007.05.005","article-title":"Detecting early pancreatic cancer: problems and prospects","volume":"34","author":"Chari","year":"2007","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.tem.2025.06.003_bb0015","series-title":"Cancer of the Pancreas. Cancer Stat Facts","author":"National Cancer Institute","year":"2018"},{"key":"10.1016\/j.tem.2025.06.003_bb0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MPA.0b013e318209e05d","article-title":"Diabetes and pancreatic cancer: chicken or egg?","volume":"40","author":"Magruder","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.tem.2025.06.003_bb0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","article-title":"Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer","volume":"134","author":"Chari","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2025.06.003_bb0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2025.06.003_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/09595287330180P102","article-title":"Cases and observations connected with disease of the pancreas and duodenum","volume":"18","author":"Bright","year":"1833","journal-title":"Med. Chir. Trans."},{"key":"10.1016\/j.tem.2025.06.003_bb0040","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jama.1995.03520440059037","article-title":"Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis","volume":"273","author":"Everhart","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2025.06.003_bb0045","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ejca.2011.03.003","article-title":"Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies","volume":"47","author":"Ben","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tem.2025.06.003_bb0050","article-title":"Long-term diabetes mellitus is associated with an increased risk of pancreatic cancer: a meta-analysis","volume":"10","author":"Song","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2025.06.003_bb0055","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","article-title":"Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies","volume":"92","author":"Huxley","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tem.2025.06.003_bb0060","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3892\/ol.2017.5586","article-title":"Association of elevated risk of pancreatic cancer in diabetic patients: a systematic review and meta-analysis","volume":"13","author":"Tan","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tem.2025.06.003_bb0065","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","article-title":"Probability of pancreatic cancer following diabetes: a population-based study","volume":"129","author":"Chari","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2025.06.003_bb0070","first-page":"319","article-title":"Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity\/BMI through causal inference and mediation analyses","volume":"70","author":"Molina-Montes","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.tem.2025.06.003_bb0075","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.cgh.2021.10.037","article-title":"Cost-effectiveness of a risk-tailored pancreatic cancer early detection strategy among patients with new-onset diabetes","volume":"20","author":"Wang","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2025.06.003_bb0080","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2337\/diabetes.52.7.1738","article-title":"Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance","volume":"52","author":"Basu","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2025.06.003_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114117","article-title":"Gender differences in tumor characteristics, treatment allocation and survival in stage I-III pancreatic cancer: a nationwide study","volume":"206","author":"Gehrels","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tem.2025.06.003_bb0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/SLA.0000000000002422","article-title":"New onset of diabetes and pancreatic exocrine insufficiency after pancreaticoduodenectomy for benign and malignant tumors: a systematic review and meta-analysis of long-term results","volume":"267","author":"Beger","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.tem.2025.06.003_bb0095","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","article-title":"Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus","volume":"134","author":"Pannala","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2025.06.003_bb0100","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2018.05.023","article-title":"Model to determine risk of pancreatic cancer in patients with new-onset diabetes","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2025.06.003_bb0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41580-020-00317-7","article-title":"Mechanisms controlling pancreatic islet cell function in insulin secretion","volume":"22","author":"Campbell","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tem.2025.06.003_bb0110","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz224","article-title":"Paraneoplastic \u03b2 cell dedifferentiation in nondiabetic patients with pancreatic cancer","volume":"105","author":"Wang","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2025.06.003_bb0115","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ncpendmet0647","article-title":"The replication of beta cells in normal physiology, in disease and for therapy","volume":"3","author":"Butler","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2025.06.003_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109223","article-title":"Pancreatic cancer-associated diabetes mellitus is characterized by reduced \u03b2-cell secretory capacity, rather than insulin resistance","volume":"185","author":"Bao","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.tem.2025.06.003_bb0125","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1210\/endo.137.6.8641217","article-title":"Regulation of insulin secretion and blood glucose metabolism by adrenomedullin","volume":"137","author":"Mart\u00ednez","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2025.06.003_bb0130","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1053\/j.gastro.2012.08.044","article-title":"Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in \u03b2 cells and mice","volume":"143","author":"Aggarwal","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2025.06.003_bb0135","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1016\/j.yexcr.2007.06.013","article-title":"Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia","volume":"313","author":"Natsuizaka","year":"2007","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tem.2025.06.003_bb0140","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/1078-0432.CCR-14-2022","article-title":"Pancreatic cancer-derived exosomes cause paraneoplastic \u03b2-cell dysfunction","volume":"21","author":"Javeed","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2025.06.003_bb0145","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/gutjnl-2014-308350","article-title":"Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue","volume":"65","author":"Sagar","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.tem.2025.06.003_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-5793(00)02110-4","article-title":"Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice","volume":"483","author":"Pitari","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tem.2025.06.003_bb0155","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/ajg.2010.32","article-title":"Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles","volume":"105","author":"Huang","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tem.2025.06.003_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.canlet.2015.12.031","article-title":"VNN1, a potential biomarker for pancreatic cancer-associated new-onset diabetes, aggravates paraneoplastic islet dysfunction by increasing oxidative stress","volume":"373","author":"Kang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tem.2025.06.003_bb0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3892\/or.2023.8557","article-title":"VNN1 overexpression in pancreatic cancer cells inhibits paraneoplastic islet function by increasing oxidative stress and inducing \u03b2-cell dedifferentiation","volume":"49","author":"Qin","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tem.2025.06.003_bb0170","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","article-title":"Pancreatic \u03b2 cell dedifferentiation as a mechanism of diabetic \u03b2 cell failure","volume":"150","author":"Talchai","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tem.2025.06.003_bb0175","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/1753-0407.12313","article-title":"Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus","volume":"8","author":"Dai","year":"2016","journal-title":"J. Diabetes"},{"key":"10.1016\/j.tem.2025.06.003_bb0180","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.7150\/ijbs.56271","article-title":"Pancreatic cancer-derived exosomal microRNA-19a induces \u03b2-cell dysfunction by targeting ADCY1 and EPAC2","volume":"17","author":"Pang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tem.2025.06.003_bb0185","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s11033-021-06980-z","article-title":"Exosomal miR-19a decreases insulin production by targeting Neurod1 in pancreatic cancer associated diabetes","volume":"49","author":"Su","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tem.2025.06.003_bb0190","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1479-5876-12-92","article-title":"Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of \u03b2-cell","volume":"12","author":"Tan","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tem.2025.06.003_bb0195","first-page":"1407","article-title":"Increased alpha cell to beta cell ratio in patients with pancreatic cancer","volume":"69","author":"Tsuchiya","year":"2022","journal-title":"Endocrinol. J."},{"key":"10.1016\/j.tem.2025.06.003_bb0200","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4161\/cbt.8.16.9006","article-title":"Glucagon\/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus","volume":"8","author":"Kolb","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tem.2025.06.003_bb0205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12020-013-0159-9","article-title":"Glucagon\/insulin ratio in preoperative screening before pancreatic surgery: correlation with hemoglobin A1C in subjects with and without pancreatic cancer","volume":"47","author":"Jin","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.tem.2025.06.003_bb0210","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/jdi.12841","article-title":"Human pancreatic \u03b1- to \u03b2-cell area ratio increases after type 2 diabetes onset","volume":"9","author":"Fujita","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.tem.2025.06.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027445","article-title":"Altered islet composition and disproportionate loss of large islets in patients with type 2 diabetes","volume":"6","author":"Kilimnik","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2025.06.003_bb0220","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-023-05967-8","article-title":"Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production","volume":"66","author":"Riahi","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2025.06.003_bb0225","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/pr.115.011395","article-title":"Glucagon-like peptide-1 and its class B G protein-coupled receptors: a long march to therapeutic successes","volume":"68","author":"Graaf","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tem.2025.06.003_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.721135","article-title":"GLP-1 receptor agonists: beyond their pancreatic effects","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tem.2025.06.003_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tem.2025.06.003_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155198","article-title":"Effects of ileal glucose infusion on enteropancreatic hormone secretion in humans: relationship to glucose absorption","volume":"131","author":"Zhang","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.tem.2025.06.003_bb0245","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","article-title":"Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine","volume":"140","author":"Hansen","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2025.06.003_bb0250","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2337\/diabetes.53.3.654","article-title":"Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects","volume":"53","author":"Meier","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2025.06.003_bb0255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/joe.0.1380159","article-title":"Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns","volume":"138","author":"Elliott","year":"1993","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tem.2025.06.003_bb0260","doi-asserted-by":"crossref","first-page":"16768","DOI":"10.1074\/jbc.M110.192799","article-title":"Glucagon-like peptide 1 stimulates post-translational activation of glucokinase in pancreatic beta cells","volume":"286","author":"Ding","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2025.06.003_bb0265","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1210\/en.2001-210979","article-title":"Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion","volume":"143","author":"Hui","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2025.06.003_bb0270","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.amjmed.2009.03.014","article-title":"Incretin therapies: effects beyond glycemic control","volume":"122","author":"Mudaliar","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.tem.2025.06.003_bb0275","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2337\/db09-0551","article-title":"Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants","volume":"58","author":"Nicolson","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2025.06.003_bb0280","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/BJ20090530","article-title":"Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion","volume":"421","author":"Pound","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.tem.2025.06.003_bb0285","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.2337\/diabetes.53.9.2330","article-title":"Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules","volume":"53","author":"Chimienti","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2025.06.003_bb0290","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1074\/jbc.M115.640524","article-title":"Characterization of zinc influx transporters (ZIPs) in pancreatic \u03b2 cells: roles in regulating cytosolic zinc homeostasis and insulin secretion","volume":"290","author":"Liu","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2025.06.003_bb0295","doi-asserted-by":"crossref","first-page":"11529","DOI":"10.1074\/jbc.RA120.014368","article-title":"Discordance between GLP-1R gene and protein expression in mouse pancreatic islet cells","volume":"295","author":"Gray","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2025.06.003_bb0300","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.canlet.2018.05.027","article-title":"Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1 cells in vitro by down-regulating the PCSK1\/3","volume":"431","author":"Zhang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tem.2025.06.003_bb0305","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/dom.12291","article-title":"Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K\/Akt pathway","volume":"16","author":"Zhao","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2025.06.003_bb0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pan.2016.12.004","article-title":"Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss","volume":"17","author":"\u0160krha","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.tem.2025.06.003_bb0315","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tem.2025.01.002","article-title":"Glucagon-like peptide-1 receptor agonism and end-organ protection","volume":"36","author":"Daniels","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2025.06.003_bb0320","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/cancers16091625","article-title":"The use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus does not increase the risk of pancreatic cancer: a U.S.-based cohort study","volume":"16","author":"Ayoub","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.tem.2025.06.003_bb0325","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50408","article-title":"Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk in patients with type 2 diabetes","volume":"7","author":"Dankner","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tem.2025.06.003_bb0330","doi-asserted-by":"crossref","first-page":"E1431","DOI":"10.1152\/ajpendo.00017.2014","article-title":"Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner","volume":"306","author":"Zhao","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2025.06.003_bb0335","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cmet.2019.07.003","article-title":"Endogenous hyperinsulinemia contributes to pancreatic cancer development","volume":"30","author":"Zhang","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2025.06.003_bb0340","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.diabet.2012.08.011","article-title":"Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies","volume":"38","author":"Colmers","year":"2012","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.tem.2025.06.003_bb0345","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic therapies affect risk of pancreatic cancer","volume":"137","author":"Li","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2025.06.003_bb0350","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ajg.2013.7","article-title":"Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"108","author":"Singh","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tem.2025.06.003_bb0355","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.celrep.2017.02.013","article-title":"Autocrine IGF1 signaling mediates pancreatic tumor cell dormancy in the absence of oncogenic drivers","volume":"18","author":"Rajbhandari","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2025.06.003_bb0360","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00006676-200303000-00014","article-title":"Impaired insulin action on phosphatidylinositol 3-kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients","volume":"26","author":"Isaksson","year":"2003","journal-title":"Pancreas"},{"key":"10.1016\/j.tem.2025.06.003_bb0365","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.nut.2010.08.022","article-title":"Mechanisms for skeletal muscle insulin resistance in patients with pancreatic ductal adenocarcinoma","volume":"27","author":"Agustsson","year":"2011","journal-title":"Nutrition"},{"key":"10.1016\/j.tem.2025.06.003_bb0370","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrgastro.2013.49","article-title":"New insights into pancreatic cancer-induced paraneoplastic diabetes","volume":"10","author":"Sah","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2025.06.003_bb0375","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccr.2012.10.025","article-title":"Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma","volume":"22","author":"Kopp","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tem.2025.06.003_bb0380","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1947601911412376","article-title":"Therapeutic strategies for targeting ras proteins","volume":"2","author":"Gysin","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.tem.2025.06.003_bb0385","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41401-020-00584-2","article-title":"Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications","volume":"42","author":"Hu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.tem.2025.06.003_bb0390","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.2147\/DMSO.S430443","article-title":"Pancreatic cancer-derived exosomal miR-Let-7b-5p stimulates insulin resistance in skeletal muscle cells through RNF20\/STAT3\/FOXO1 axis regulation","volume":"16","author":"Wang","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.tem.2025.06.003_bb0395","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1038\/s41598-017-05541-4","article-title":"Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K\/Akt\/FoxO1 pathway","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2025.06.003_bb0400","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJM199402033300503","article-title":"Islet amyloid polypeptide in patients with pancreatic cancer and diabetes","volume":"330","author":"Permert","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2025.06.003_bb0405","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1053\/gast.2001.27210","article-title":"Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer","volume":"121","author":"Chari","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2025.06.003_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101667","article-title":"Islet amyloid polypeptide does not suppress pancreatic cancer","volume":"68","author":"Taylor","year":"2023","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tem.2025.06.003_bb0415","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2025.06.003_bb0420","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur. Cardiol."},{"key":"10.1016\/j.tem.2025.06.003_bb0425","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2025.06.003_bb0430","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/jcm12030756","article-title":"Associations between systemic immune-inflammation index and diabetes mellitus secondary to pancreatic ductal adenocarcinoma","volume":"12","author":"Chen","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tem.2025.06.003_bb0435","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tem.2025.06.003_bb0440","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1096\/fj.09-151340","article-title":"JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction","volume":"24","author":"Solinas","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2025.06.003_bb0445","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1002\/jcp.29605","article-title":"Transforming growth factor-\u03b2 signaling, a potential mechanism associated with diabetes mellitus and pancreatic cancer?","volume":"235","author":"Ma","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tem.2025.06.003_bb0450","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1172\/JCI71526","article-title":"Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-\u03b2 to promote proliferation","volume":"124","author":"Gore","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2025.06.003_bb0455","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5582\/bst.2014.01092","article-title":"Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes","volume":"8","author":"Shi","year":"2014","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.tem.2025.06.003_bb0460","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cca.2016.02.018","article-title":"Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus","volume":"456","author":"Moz","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.tem.2025.06.003_bb0465","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2337\/dc19-0217","article-title":"Galectin-3 and S100A9: novel diabetogenic factors mediating pancreatic cancer-associated diabetes","volume":"42","author":"Liao","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2025.06.003_bb0470","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2014.08.001","article-title":"Hypoxia inducible factor (HIF)-1\u03b1 directly activates leptin receptor (Ob-R) in pancreatic cancer cells","volume":"354","author":"Ren","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tem.2025.06.003_bb0475","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/0008-5472.CAN-13-1558-T","article-title":"Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.tem.2025.06.003_bb0480","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3390\/cancers12071849","article-title":"The role of dysfunctional adipose tissue in pancreatic cancer: a molecular perspective","volume":"12","author":"Brocco","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.tem.2025.06.003_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.151012","article-title":"Crosstalk between pancreatic cancer and adipose tissue: Molecular mechanisms and therapeutic implications","volume":"740","author":"Diao","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2025.06.003_bb0490","doi-asserted-by":"crossref","first-page":"20223","DOI":"10.18632\/oncotarget.7936","article-title":"Adipocytes WNT5a mediated dedifferentiation: a possible target in pancreatic cancer microenvironment","volume":"7","author":"Zoico","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tem.2025.06.003_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2025.03.007","article-title":"Integrating cancer medicine into metabolic rhythms","author":"Su","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2025.06.003_bb0500","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41573-020-00109-w","article-title":"Circadian rhythm as a therapeutic target","volume":"20","author":"Ruan","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tem.2025.06.003_bb0505","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab089","article-title":"Circadian regulation of the pancreatic beta cell","volume":"162","author":"Seshadri","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2025.06.003_bb0510","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbrc.2016.02.087","article-title":"Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma","volume":"472","author":"Li","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2025.06.003_bb0515","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.canlet.2015.12.002","article-title":"The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway","volume":"371","author":"Jiang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tem.2025.06.003_bb0520","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/07420528.2014.1003351","article-title":"SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: effect of starvation","volume":"32","author":"Tavano","year":"2015","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.tem.2025.06.003_bb0525","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41419-017-0233-y","article-title":"The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance","volume":"9","author":"Jiang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tem.2025.06.003_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010770","article-title":"The circadian clock is disrupted in pancreatic cancer","volume":"19","author":"Schwartz","year":"2023","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tem.2025.06.003_bb0535","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature09253","article-title":"Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes","volume":"466","author":"Marcheva","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.tem.2025.06.003_bb0540","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.chom.2024.07.017","article-title":"The central role of the gut microbiota in the pathophysiology and management of type 2 diabetes","volume":"32","author":"Baars","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tem.2025.06.003_bb0545","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tem.2025.06.003_bb0550","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.3390\/cancers14184479","article-title":"The role of the microbiome in pancreatic cancer","volume":"14","author":"Miyabayashi","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.tem.2025.06.003_bb0555","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tem.2025.06.003_bb0560","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.998600","article-title":"Periodontitis induced by Porphyromonas gingivalis drives impaired glucose metabolism in mice","volume":"12","author":"Kang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tem.2025.06.003_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104821","article-title":"Gut microbiota in the pathogenesis and therapeutic approaches of diabetes","volume":"97","author":"Crudele","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tem.2025.06.003_bb0570","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2111951","article-title":"Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction","volume":"14","author":"Scheithauer","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.tem.2025.06.003_bb0575","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature18646","article-title":"Human gut microbes impact host serum metabolome and insulin sensitivity","volume":"535","author":"Pedersen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tem.2025.06.003_bb0580","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.3390\/cancers12123522","article-title":"Lactobacillus attenuate the progression of pancreatic cancer promoted by Porphyromonas gingivalis in K-rasG12D transgenic mice","volume":"12","author":"Chen","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tem.2025.06.003_bb0585","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/nu17010074","article-title":"Plasma bacterial metabolites in Crohn's disease pathogenesis and complications","volume":"17","author":"Deskur","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.tem.2025.06.003_bb0590","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tem.2025.06.003_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.809495","article-title":"Visualization-Based discovery of vanin-1 inhibitors for colitis","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.tem.2025.06.003_bb0600","doi-asserted-by":"crossref","first-page":"20372","DOI":"10.1021\/acs.jmedchem.4c01838","article-title":"Discovery of thiazole carboxamides as novel vanin-1 inhibitors for inflammatory bowel disease treatment","volume":"67","author":"Xie","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tem.2025.06.003_bb0605","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijbiomac.2022.06.014","article-title":"Discovery and characterization of dual inhibitors of human Vanin-1 and Vanin-2 enzymes through molecular docking and dynamic simulation-based approach","volume":"213","author":"Nawaz","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tem.2025.06.003_bb0610","first-page":"862","article-title":"A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer","volume":"47","author":"Ikeda","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.tem.2025.06.003_bb0615","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1021\/acsptsci.0c00032","article-title":"Discovery of a first-in-class potent small molecule antagonist against the adrenomedullin-2 receptor","volume":"3","author":"Avgoustou","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.tem.2025.06.003_bb0620","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/onc.2016.306","article-title":"RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.tem.2025.06.003_bb0625","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.gastro.2024.03.007","article-title":"Genetic deletion of galectin-3 inhibits pancreatic cancer progression and enhances the efficacy of immunotherapy","volume":"167","author":"Yang","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2025.06.003_bb0630","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276025001262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276025001262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:02:45Z","timestamp":1777075365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276025001262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":126,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1043276025001262"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2025.06.003","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the sweet connection between pancreatic cancer and hyperglycemia","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2025.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}